✦ LIBER ✦

A pooled analysis of the incidences of treatment-emergent adverse events associated with discontinuation in phase 2/3 studies of tapentadol IR

✍ Scribed by D. Upmalis; H. Pei; A. Okamoto; F. Laschewski; C. Rauschkolb-Löffler; J. Häussler; T. Häufel; C. Lange; C. Oh

Book ID: 118476376
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 39 KB
Volume: 10
Category: Article
ISSN: 1528-8447
DOI: 10.1016/j.jpain.2009.01.176

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relative association of treatment-emerge

Relative association of treatment-emergent adverse events with quality of life of patients with schizophrenia: post hoc analysis from a 3-year observational study

✍ Cecilia Adrianzén; Cesar Arango-Dávila; Danilo Martínez Araujo; Ignacio Ruíz; Ri 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

## Abstract ## Objective To explore the relative association of adverse events with health‐related quality of life (HRQL) in patients (__N__ = 16 091) with schizophrenia, treated with antipsychotic medication. ## Methods In this __post hoc__ analysis of data from two 3‐year observational studies

401 The incidence of antimuscarinic-asso

401 The incidence of antimuscarinic-associated side effects in overactive bladder (OAB) patients treated with mirabegron: Results of a pooled analysis of 3 randomised phase 3 trials

✍ Nitti, V.; Chapple, C.R.; Amarenco, G.; Radziszewski, P.; Angulo, J.; Blauwet, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 294 KB

469 Incidence of selected adverse events

469 Incidence of selected adverse events (AEs) in phase III studies of bevacizumab (BV) in combination with chemotherapy for the treatment of HER2-negative metastatic breast cancer (mBC)

✍ D.W. Miles; V. Dieras; J. Glaspy; A. Brufsky; P. Koralewski; S.C. Phan; N.J. Rob 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

The incidence of arthropathy adverse eve

The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumab

✍ Carlo Pincelli; Eric Henninger; Florence Casset-Semanaz 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 475 KB

(761): A randomized, double-blind, place

(761): A randomized, double-blind, placebo-controlled, multicenter phase IIb study to evaluate the efficacy and safety of multiple alvimopan dosage regimens for the treatment of gastrointestinal adverse events (GIAEs) associated with opioid use in subjects

✍ L. Webster; J. Jansen; J. Peppin; B. Lasko; J. Snidow; A. Pierce; E. Mortensen; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB